| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| ORLADEYO | $66.29M | $71.05M | $76.28M | $90.49M | $87.58M | $88.03M | $92.35M | $102.29M |
| License and other revenues | — | — | — | — | — | — | — | $6.6M |
| Peramivir | — | — | — | $1.2M | $381K | $153K | $10.49M | $381K |
| Total | $2.12M | $1M | $79.07M | $93.39M | $91.18M | $91.33M | $106.82M | $109.27M |